ClinicalTrials.Veeva

Menu

Readmission in the Case of Patients With Heart Failure (PRADO-IC)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Heart Failure

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Heart failure (HF) is a serious chronic disease with frequent readmissions, some of which can be prevented by early action. The management of HF is complex: long, often difficult and costly. In France, nearly one million people suffer from HF and 120,000 new cases are diagnosed every year. With the aging population, this number will continue to evolve and become a real public health problem. Within 10 to 20 years ahead, WHO projects that heart failure in either the 3 most common diseases in industrialized countries.

Investigators goals are to make an inventory of PRADO-IC project in terms of its effectiveness on readmission of patients with heart failure.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient aged 18 or over
  • Patient readmitted for heart failure

Exclusion criteria

  • Population whose age is less than 18 years

Trial contacts and locations

1

Loading...

Central trial contact

Emmanuel ANDRES, MD, PhD; Mylène Radreau, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems